These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1115 related items for PubMed ID: 29759518

  • 21. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death.
    Elbayomi M, Weyand M, Seitz T, Harig F.
    Ann Noninvasive Electrocardiol; 2023 Mar; 28(2):e13048. PubMed ID: 36723848
    [Abstract] [Full Text] [Related]

  • 22. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, Zareba W, Goldenberg I.
    Circulation; 2015 Oct 27; 132(17):1613-9. PubMed ID: 26316618
    [Abstract] [Full Text] [Related]

  • 23. Wearable Cardioverter-Defibrillators following Cardiac Surgery-A Single-Center Experience.
    Heimeshoff J, Merz C, Ricklefs M, Kirchhoff F, Haverich A, Bara C, Kühn C.
    Thorac Cardiovasc Surg; 2019 Mar 27; 67(2):92-97. PubMed ID: 29925094
    [Abstract] [Full Text] [Related]

  • 24. Physical activity is reduced prior to ventricular arrhythmias in patients with a wearable cardioverter defibrillator.
    Burch AE, D'Souza B, Gimbel JR, Rohrer U, Masuda T, Sears S, Scherr D.
    Clin Cardiol; 2020 Jan 27; 43(1):60-65. PubMed ID: 31710766
    [Abstract] [Full Text] [Related]

  • 25. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM, Bense J, Hohenforst-Schmidt W.
    J Interv Card Electrophysiol; 2021 Nov 27; 62(2):401-407. PubMed ID: 33200285
    [Abstract] [Full Text] [Related]

  • 26. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report.
    Andresen H, Sasko B, Patschan D, Pagonas N, Ritter O.
    J Med Case Rep; 2021 May 17; 15(1):243. PubMed ID: 33993888
    [Abstract] [Full Text] [Related]

  • 27. Indications for an implantable cardioverter defibrillator (ICD).
    Aizawa Y, Chinushi M, Washizuka T.
    Intern Med; 2004 May 17; 43(5):360-7. PubMed ID: 15206546
    [Abstract] [Full Text] [Related]

  • 28. Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience.
    Sasaki S, Shoji Y, Ishida Y, Kinjo T, Tsushima Y, Seno M, Nishizaki F, Itoh T, Izumiyama K, Yokota T, Yokoyama H, Yamada M, Horiuchi D, Kimura M, Higuma T, Tomita H, Okumura K.
    J Cardiol; 2017 Jan 17; 69(1):359-363. PubMed ID: 27595899
    [Abstract] [Full Text] [Related]

  • 29. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU, Goldenberg I, Moss AJ.
    Eur Heart J; 2013 Aug 17; 34(29):2230-42. PubMed ID: 23729691
    [Abstract] [Full Text] [Related]

  • 30. Wearable cardioverter defibrillator multicentre experience in a large cardiac surgery cohort at transient risk of sudden cardiac death.
    Kuehn C, Ruemke S, Rellecke P, Lichtenberg A, Joskowiak D, Hagl C, Hassan M, Leyh RG, Erler S, Garbade J, Eifert S, Grieshaber P, Boening A, Doenst T, Velichkov I, Madej T, Knaut M, Hain A, Burger H.
    Eur J Cardiothorac Surg; 2022 May 02; 61(5):1031-1040. PubMed ID: 35174386
    [Abstract] [Full Text] [Related]

  • 31. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis.
    Opreanu M, Wan C, Singh V, Salehi N, Ahmad J, Szymkiewicz SJ, Thakur RK.
    J Heart Lung Transplant; 2015 Oct 02; 34(10):1305-9. PubMed ID: 26094085
    [Abstract] [Full Text] [Related]

  • 32. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD).
    Guerra F, Palmisano P, Dell'Era G, Ziacchi M, Ammendola E, Bonelli P, Patani F, Cupido C, Devecchi C, Accogli M, Occhetta E, Santangelo L, Biffi M, Boriani G, Capucci A, Italian Association of Arrhythmology and Cardiac Pacing (AIAC).
    Heart Rhythm; 2016 Oct 02; 13(10):1987-92. PubMed ID: 27291511
    [Abstract] [Full Text] [Related]

  • 33. Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.
    Zareba W, Daubert JP, Beck CA, Huang DT, Alexis JD, Brown MW, Pyykkonen K, McNitt S, Oakes D, Feng C, Aktas MK, Ayala-Parades F, Baranchuk A, Dubuc M, Haigney M, Mazur A, McPherson CA, Mitchell LB, Natale A, Piccini JP, Raitt M, Rashtian MY, Schuger C, Winters S, Worley SJ, Ziv O, Moss AJ, RAID Trial Investigators.
    J Am Coll Cardiol; 2018 Aug 07; 72(6):636-645. PubMed ID: 30071993
    [Abstract] [Full Text] [Related]

  • 34. Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry.
    Veltmann C, Winter S, Duncker D, Jungbauer CG, Wäßnig NK, Geller JC, Erath JW, Goeing O, Perings C, Ulbrich M, Roser M, Husser D, Gansera LS, Soezener K, Malur FM, Block M, Fetsch T, Kutyifa V, Klein HU.
    Clin Res Cardiol; 2021 Jan 07; 110(1):102-113. PubMed ID: 32377784
    [Abstract] [Full Text] [Related]

  • 35. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D, König T, Hohmann S, Bauersachs J, Veltmann C.
    J Am Heart Assoc; 2017 Jan 17; 6(1):. PubMed ID: 28096098
    [Abstract] [Full Text] [Related]

  • 36. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
    Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, Friedman PL, Martins JB, Epstein AE, Hallstrom AP, Ledingham RB, Belco KM, Greene HL, AVID Investigators.
    J Cardiovasc Electrophysiol; 2003 Sep 17; 14(9):940-8. PubMed ID: 12950538
    [Abstract] [Full Text] [Related]

  • 37. One-year follow-up of the prospective registry of patients using the wearable defibrillator (WEARIT-II Registry).
    Kutyifa V, Moss AJ, Klein HU, McNitt S, Zareba W, Goldenberg I.
    Pacing Clin Electrophysiol; 2018 Oct 17; 41(10):1307-1313. PubMed ID: 29992590
    [Abstract] [Full Text] [Related]

  • 38. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD.
    J Cardiovasc Electrophysiol; 2012 Mar 17; 23(3):296-301. PubMed ID: 21955243
    [Abstract] [Full Text] [Related]

  • 39. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
    Skowasch D, Ringquist S, Nickenig G, Andrié R.
    PLoS One; 2018 Mar 17; 13(3):e0194496. PubMed ID: 29566033
    [Abstract] [Full Text] [Related]

  • 40. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH, Lin YJ, Huang JL, Wu TJ, Cheng CC, Lin WS, Tuan TC, Chang SL, Lo LW, Hu YF, Chao TF, Chung FP, Tsai CF, Tsao HM, Chen SA.
    J Cardiovasc Electrophysiol; 2012 Jul 17; 23(7):750-6. PubMed ID: 22353378
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.